ATE488238T1 - Verwendung von thiazolbenzo-heterocyclenfür die behandlung von multipler sklerose - Google Patents
Verwendung von thiazolbenzo-heterocyclenfür die behandlung von multipler skleroseInfo
- Publication number
- ATE488238T1 ATE488238T1 AT03814050T AT03814050T ATE488238T1 AT E488238 T1 ATE488238 T1 AT E488238T1 AT 03814050 T AT03814050 T AT 03814050T AT 03814050 T AT03814050 T AT 03814050T AT E488238 T1 ATE488238 T1 AT E488238T1
- Authority
- AT
- Austria
- Prior art keywords
- multiple sclerosis
- thiazolbenzo
- heterocycles
- treatment
- inflammatory
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 206010065390 Inflammatory pain Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43400302P | 2002-12-17 | 2002-12-17 | |
| PCT/US2003/040078 WO2004058271A1 (en) | 2002-12-17 | 2003-12-16 | Use of thiazolobenzoheterocycles for treating multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE488238T1 true ATE488238T1 (de) | 2010-12-15 |
Family
ID=23722415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03814050T ATE488238T1 (de) | 2002-12-17 | 2003-12-16 | Verwendung von thiazolbenzo-heterocyclenfür die behandlung von multipler sklerose |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7041661B2 (de) |
| EP (1) | EP1585525B1 (de) |
| AT (1) | ATE488238T1 (de) |
| AU (1) | AU2003300976A1 (de) |
| BR (1) | BR0317413A (de) |
| CA (1) | CA2508222A1 (de) |
| DE (1) | DE60335029D1 (de) |
| GB (1) | GB0307067D0 (de) |
| MX (1) | MXPA05006296A (de) |
| WO (1) | WO2004058271A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010031054A1 (en) | 2008-09-15 | 2010-03-18 | Biovista, Inc. | Compositions and methods for treating epilepsy |
| WO2013130422A1 (en) | 2012-02-27 | 2013-09-06 | Biovista, Inc. | Compositions and methods for treating mitochondrial diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2649701B2 (fr) * | 1988-12-15 | 1991-11-22 | Rhone Poulenc Sante | Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant |
| FR2766487B1 (fr) * | 1997-07-28 | 1999-08-27 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
| FR2826004B1 (fr) | 2001-06-13 | 2008-03-28 | Aventis Pharma Sa | Procede de preparation de derives estrogenes |
-
2003
- 2003-03-27 GB GBGB0307067.9A patent/GB0307067D0/en not_active Ceased
- 2003-12-16 WO PCT/US2003/040078 patent/WO2004058271A1/en not_active Ceased
- 2003-12-16 EP EP03814050A patent/EP1585525B1/de not_active Expired - Lifetime
- 2003-12-16 DE DE60335029T patent/DE60335029D1/de not_active Expired - Lifetime
- 2003-12-16 MX MXPA05006296A patent/MXPA05006296A/es unknown
- 2003-12-16 BR BR0317413-1A patent/BR0317413A/pt not_active Application Discontinuation
- 2003-12-16 AT AT03814050T patent/ATE488238T1/de not_active IP Right Cessation
- 2003-12-16 CA CA002508222A patent/CA2508222A1/en not_active Abandoned
- 2003-12-16 US US10/737,634 patent/US7041661B2/en not_active Expired - Lifetime
- 2003-12-16 AU AU2003300976A patent/AU2003300976A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1585525A1 (de) | 2005-10-19 |
| BR0317413A (pt) | 2005-11-08 |
| MXPA05006296A (es) | 2005-08-29 |
| GB0307067D0 (en) | 2003-04-30 |
| DE60335029D1 (de) | 2010-12-30 |
| WO2004058271A1 (en) | 2004-07-15 |
| US7041661B2 (en) | 2006-05-09 |
| CA2508222A1 (en) | 2004-07-15 |
| US20040147504A1 (en) | 2004-07-29 |
| AU2003300976A1 (en) | 2004-07-22 |
| EP1585525B1 (de) | 2010-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
| ATE416761T1 (de) | Prävention und behandlung von durch entzündung ausgelöstem und/oder immunvermitteltem knochenschwund | |
| IS8058A (is) | Sýklísk súlfónamíð til að hamla gamma seytiasa | |
| DE60224879D1 (de) | Verwendung von dpiv-inhibitoren als therapeutika für krankhafte neurologische zustände | |
| ATE464323T1 (de) | Zusammensetzungen und verfahren für die tumor- diagnose und behandlung | |
| ATE414697T1 (de) | Nf-kb-inhibitoren | |
| ATE539751T1 (de) | Verwendung von brimonidine zur behandlung von stress assoziierten zuständen | |
| ATE429916T1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
| DE60231050D1 (de) | Verwendung von Totarol zur Behandlung von Pruritus | |
| ECSP024244A (es) | Uso de (z)-2-cyano-3-hydroxy-but-2-enoic acid(4´-trifluoromethylphenyl)-amide para el tratamiento de la esclerosis múltiple | |
| ATE323084T1 (de) | Für die behandlung von alzheimer krankheit geeignete makrocyclen | |
| DE60220385D1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| ATE494296T1 (de) | Zusammensetzungen und verfahren für die tumordiagnose und behandlung | |
| DE602005020263D1 (de) | Für die behandlung von entzündlichen krankheiten nützliche beta-carboline | |
| ECSP055844A (es) | Nuevos compuestos triciclicos | |
| ATE443044T1 (de) | Tace inhibitoren | |
| ATE512147T1 (de) | Makrozyklische aminiopyridyl-beta-sekretase- hemmer zur behandlung von morbus alzheimer | |
| ATE346040T1 (de) | Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit | |
| DE60335029D1 (de) | Verwendung von thiazolbenzo-heterocyclenfür die behandlung von multipler sklerose | |
| ATE423102T1 (de) | 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer | |
| ATE453386T1 (de) | Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten | |
| ATE358673T1 (de) | Nf-kb-inhibitoren | |
| TW200600084A (en) | Anti-coronavirus compounds | |
| ATE534380T1 (de) | Glepp-1-hemmer bei der behandlung von autoimmun- und/oder entzündungskrankheiten | |
| NO20033541L (no) | Anvendelse av fosfodiesteraseinhibitorer av type 4 ved hjertemuskelsykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |